Totally implantable venous access ports: A prospective randomized study comparing subclavian and internal jugular vein punctures in children
- PMID: 32467037
- DOI: 10.1016/j.jpedsurg.2020.04.021
Totally implantable venous access ports: A prospective randomized study comparing subclavian and internal jugular vein punctures in children
Abstract
Background and objectives: Totally implantable venous access ports (TIVAPs) are essential in children who require long-term intermittent intravenous therapy.
Methods: Patients who needed to undergo TIVAP implantation were randomly assigned to the internal jugular vein group or the subclavian vein group. The medical histories, operative details and major complications from the time of port implantation to 48 h after port removal were collected. During the use of TIVAPs, satisfaction surveys were regularly conducted for the children and guardians and compared in the two groups.
Results: A total of 216 patients in the subclavian vein group and 199 patients in the internal jugular vein group were included. TIVAPs were successfully implanted in all children. The incidence of postoperative venous access occlusion in the subclavian vein group and internal jugular vein group was 1.5% and 5%, respectively, and the difference was statistically significant (P < 0.05). The average satisfaction score of the children and guardians in the subclavian vein group was 9.6 ± 0.3, and that in the internal jugular vein group was 8.3 ± 0.8. There was a significant difference between the 2 groups (P < 0.05).
Conclusions: Subclavian vein should be the first choice for TIVAP implantation in children.
The level of evidence rating: Treatment study level I.
Keywords: Central venipuncture; Internal jugular vein; Pinch-off syndrome; Subclavian vein; Totally implantable venous access ports.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
-
Totally implantable venous access ports: A systematic review and meta-analysis comparing subclavian and internal jugular vein punctures.Phlebology. 2022 May;37(4):279-288. doi: 10.1177/02683555211069772. Epub 2022 Feb 24. Phlebology. 2022. PMID: 35200052
-
Internal jugular vein versus external jugular vein as the insertion site for totally implantable venous access ports in children: a randomized comparative study.Pediatr Surg Int. 2025 Feb 12;41(1):78. doi: 10.1007/s00383-025-05981-4. Pediatr Surg Int. 2025. PMID: 39937326 Clinical Trial.
-
Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception.Eur J Radiol. 2011 Sep;79(3):338-42. doi: 10.1016/j.ejrad.2009.12.010. Epub 2010 Mar 12. Eur J Radiol. 2011. PMID: 20227211
-
Long-term complications in totally implantable venous access devices: randomized study comparing subclavian and internal jugular vein puncture.Pediatr Blood Cancer. 2012 Feb;58(2):274-7. doi: 10.1002/pbc.23220. Epub 2011 Jun 14. Pediatr Blood Cancer. 2012. PMID: 21674765 Clinical Trial.
-
Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta-analysis.J Thromb Haemost. 2020 Sep;18(9):2253-2273. doi: 10.1111/jth.14930. Epub 2020 Jul 15. J Thromb Haemost. 2020. PMID: 32479699
Cited by
-
Tunneled Hemodialysis Catheter Insertion: Technical and Clinical Considerations.Indian J Radiol Imaging. 2022 Dec 7;33(1):76-79. doi: 10.1055/s-0042-1758877. eCollection 2023 Jan. Indian J Radiol Imaging. 2022. PMID: 36855721 Free PMC article. Review.
-
Comparing internal jugular vein and subclavian vein for central venous insertion of implantable ports in cancer chemotherapy: a meta-analysis of RCTs.Front Oncol. 2025 May 26;15:1566757. doi: 10.3389/fonc.2025.1566757. eCollection 2025. Front Oncol. 2025. PMID: 40492120 Free PMC article.
-
Pacemaker leads as a potential source of problems in patients who might need a central venous access port.Cardiovasc Diagn Ther. 2023 Dec 15;13(6):1068-1079. doi: 10.21037/cdt-23-104. Epub 2023 Oct 27. Cardiovasc Diagn Ther. 2023. PMID: 38162103 Free PMC article.
-
Intelligent Internet of Things Medical Technology in Implantable Intravenous Infusion Port in Children with Malignant Tumors.J Healthc Eng. 2021 Nov 28;2021:8936820. doi: 10.1155/2021/8936820. eCollection 2021. J Healthc Eng. 2021. Retraction in: J Healthc Eng. 2023 Oct 18;2023:9806870. doi: 10.1155/2023/9806870. PMID: 34876968 Free PMC article. Retracted.
-
Comparison of peripherally inserted central catheters (PICCs) versus totally implantable venous-access ports in pediatric oncology patients, a single center study.Sci Rep. 2022 Mar 3;12(1):3510. doi: 10.1038/s41598-022-07584-8. Sci Rep. 2022. PMID: 35241771 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials